Cargando…
The COVID-19 pandemic posed many dilemmas for policymakers, which sometimes resulted in unprecedented decision-making
BACKGROUND: The COVID-19 pandemic evolved through five phases, beginning with ‘the great threat’, then moving through ‘the emergence of variants', ‘vaccines euphoria’, and ‘the disillusionment’, and culminating in ‘a disease we can live with’. Each phase required a different governance response...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112313/ https://www.ncbi.nlm.nih.gov/pubmed/37072814 http://dx.doi.org/10.1186/s13584-023-00564-x |
_version_ | 1785027601420517376 |
---|---|
author | Ash, Nachman Triki, Noa Waitzberg, Ruth |
author_facet | Ash, Nachman Triki, Noa Waitzberg, Ruth |
author_sort | Ash, Nachman |
collection | PubMed |
description | BACKGROUND: The COVID-19 pandemic evolved through five phases, beginning with ‘the great threat’, then moving through ‘the emergence of variants', ‘vaccines euphoria’, and ‘the disillusionment’, and culminating in ‘a disease we can live with’. Each phase required a different governance response. With the progress of the pandemic, data were collected, evidence was created, and health technology was developed and disseminated. Policymaking shifted from protecting the population by limiting infections with non-pharmaceutical interventions to controlling the pandemic by prevention of severe disease with vaccines and drugs for those infected. Once the vaccine became available, the state started devolving the responsibility for the individual’s health and behavior. MAIN BODY: Each phase of the pandemic posed new and unique dilemmas for policymakers, which resulted in unprecedented decision-making. Restrictions to individual’s rights such as a lockdown or the ‘Green Pass policy’ were unimaginable before the pandemic. One of the most striking decisions that the Ministry of Health made was approving the third (booster) vaccine dose in Israel, before it was approved by the FDA or any other country. It was possible to make an informed, evidence-based decision due to the availability of reliable and timely data. Transparent communication with the public probably promoted adherence to the booster dose recommendation. The boosters made an important contribution to public health, even though their uptake was less than the uptake for the initial doses. The decision to approve the booster illustrates seven key lessons from the pandemic: health technology is key; leadership is crucial (both political and professional); a single body should coordinate the actions of all stakeholders involved in the response, and these should collaborate closely; policymakers need to engage the public and win their trust and compliance; data are essential to build a suitable response; and nations and international organizations should collaborate in preparing for and responding to pandemics, because viruses travel without borders. CONCLUSION: The COVID-19 pandemic posed many dilemmas for policymakers. The lessons learned from the actions taken to deal with them should be incorporated into preparedness for future challenges. |
format | Online Article Text |
id | pubmed-10112313 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-101123132023-04-20 The COVID-19 pandemic posed many dilemmas for policymakers, which sometimes resulted in unprecedented decision-making Ash, Nachman Triki, Noa Waitzberg, Ruth Isr J Health Policy Res Perspective BACKGROUND: The COVID-19 pandemic evolved through five phases, beginning with ‘the great threat’, then moving through ‘the emergence of variants', ‘vaccines euphoria’, and ‘the disillusionment’, and culminating in ‘a disease we can live with’. Each phase required a different governance response. With the progress of the pandemic, data were collected, evidence was created, and health technology was developed and disseminated. Policymaking shifted from protecting the population by limiting infections with non-pharmaceutical interventions to controlling the pandemic by prevention of severe disease with vaccines and drugs for those infected. Once the vaccine became available, the state started devolving the responsibility for the individual’s health and behavior. MAIN BODY: Each phase of the pandemic posed new and unique dilemmas for policymakers, which resulted in unprecedented decision-making. Restrictions to individual’s rights such as a lockdown or the ‘Green Pass policy’ were unimaginable before the pandemic. One of the most striking decisions that the Ministry of Health made was approving the third (booster) vaccine dose in Israel, before it was approved by the FDA or any other country. It was possible to make an informed, evidence-based decision due to the availability of reliable and timely data. Transparent communication with the public probably promoted adherence to the booster dose recommendation. The boosters made an important contribution to public health, even though their uptake was less than the uptake for the initial doses. The decision to approve the booster illustrates seven key lessons from the pandemic: health technology is key; leadership is crucial (both political and professional); a single body should coordinate the actions of all stakeholders involved in the response, and these should collaborate closely; policymakers need to engage the public and win their trust and compliance; data are essential to build a suitable response; and nations and international organizations should collaborate in preparing for and responding to pandemics, because viruses travel without borders. CONCLUSION: The COVID-19 pandemic posed many dilemmas for policymakers. The lessons learned from the actions taken to deal with them should be incorporated into preparedness for future challenges. BioMed Central 2023-04-18 /pmc/articles/PMC10112313/ /pubmed/37072814 http://dx.doi.org/10.1186/s13584-023-00564-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Perspective Ash, Nachman Triki, Noa Waitzberg, Ruth The COVID-19 pandemic posed many dilemmas for policymakers, which sometimes resulted in unprecedented decision-making |
title | The COVID-19 pandemic posed many dilemmas for policymakers, which sometimes resulted in unprecedented decision-making |
title_full | The COVID-19 pandemic posed many dilemmas for policymakers, which sometimes resulted in unprecedented decision-making |
title_fullStr | The COVID-19 pandemic posed many dilemmas for policymakers, which sometimes resulted in unprecedented decision-making |
title_full_unstemmed | The COVID-19 pandemic posed many dilemmas for policymakers, which sometimes resulted in unprecedented decision-making |
title_short | The COVID-19 pandemic posed many dilemmas for policymakers, which sometimes resulted in unprecedented decision-making |
title_sort | covid-19 pandemic posed many dilemmas for policymakers, which sometimes resulted in unprecedented decision-making |
topic | Perspective |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112313/ https://www.ncbi.nlm.nih.gov/pubmed/37072814 http://dx.doi.org/10.1186/s13584-023-00564-x |
work_keys_str_mv | AT ashnachman thecovid19pandemicposedmanydilemmasforpolicymakerswhichsometimesresultedinunprecedenteddecisionmaking AT trikinoa thecovid19pandemicposedmanydilemmasforpolicymakerswhichsometimesresultedinunprecedenteddecisionmaking AT waitzbergruth thecovid19pandemicposedmanydilemmasforpolicymakerswhichsometimesresultedinunprecedenteddecisionmaking AT ashnachman covid19pandemicposedmanydilemmasforpolicymakerswhichsometimesresultedinunprecedenteddecisionmaking AT trikinoa covid19pandemicposedmanydilemmasforpolicymakerswhichsometimesresultedinunprecedenteddecisionmaking AT waitzbergruth covid19pandemicposedmanydilemmasforpolicymakerswhichsometimesresultedinunprecedenteddecisionmaking |